1,3-dipropyl-8-cyclopentylxanthine has been researched along with Edema in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Additionally, incarvillateine attenuated mechanical allodynia induced by spared nerve injury or paclitaxel, whereas normal mechanical sensation was not affected." | 3.81 | Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis, and possible involvement of the adenosine system. ( Gong, ZH; Huang, B; Jia, YX; Su, RB; Wang, ML; Wang, ZT; Yi, SP; Yu, G; Zhang, FY, 2015) |
| "The effects of oral administration of UP 202-56, an adenosine analogue, were assessed on carrageenan-induced spinal c-Fos protein expression and peripheral oedema." | 3.70 | UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. ( Besson, JM; Buritova, J; Chapman, V; Honoré, P, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, ML | 1 |
| Yu, G | 1 |
| Yi, SP | 1 |
| Zhang, FY | 1 |
| Wang, ZT | 1 |
| Huang, B | 1 |
| Su, RB | 1 |
| Jia, YX | 1 |
| Gong, ZH | 1 |
| Honoré, P | 1 |
| Buritova, J | 1 |
| Chapman, V | 1 |
| Besson, JM | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Edema
| Article | Year |
|---|---|
Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis, and possible involvement of the adenosine system.
Topics: Adenosine; Alkaloids; Analgesics; Animals; Antineoplastic Agents, Phytogenic; Bignoniaceae; Disease | 2015 |
UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
Topics: Adenosine; Administration, Oral; Animals; Carrageenan; Edema; Hindlimb; Indoles; Male; Proto-Oncogen | 1998 |